| Page 26 | Cafepharma

You are here

Primary tabs

Evotec Receives Milestone Payment for Beginning Phase II NASH Clinical Trial

Post date: January 24, 2019 - 10:12am

Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal Regarding its Immuno-oncology Candidate, VE800

Post date: January 24, 2019 - 12:19am

Gosssamer Bio to Use 20 Day Rule for $230 Million IPO

Post date: January 23, 2019 - 9:14pm

Talee Bio Receives $4.5 Million from the Cystic Fibrosis Foundation to Expedite Development of Two Gene Therapy Candidates

Post date: January 23, 2019 - 9:37am

Microbiome Report for Week Ending 1/19/19

Post date: January 23, 2019 - 9:32am

BridgeBio Pharma Raises $299.2 Million to Support Its Genetic Disease Development Programs

Post date: January 23, 2019 - 9:22am

ENDRA Life Sciences to Enhance Ultrasound Offerings with AI and Machine Learning

Post date: January 22, 2019 - 10:53am

Microbiome Report for Week Ending 1/12/19

Post date: January 17, 2019 - 10:09am

Pappas Life Science Ventures Raises New $85.7 million investment fund

Post date: January 17, 2019 - 9:35am

European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer

Post date: January 16, 2019 - 9:52am

Pages